COMMONWEALTH OF AUSTRALIA
Instrument number PB 69 of 2012
National Health Act (Pharmaceutical Benefits – Early Supply) Amendment September 2012 - specification under subsection 84AAA(2)1
 
Amendment determination under subsection 84AAA(2) of the National Health Act 1953
 
I, Adriana Platona, Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.
 
Dated         15 August 2012
 
 
ADRIANA PLATONA
Assistant Secretary
Pharmaceutical Evaluation Branch
Department of Health and Ageing
 
 
 
Amendment determination — Pharmaceutical Benefits - Early Supply
 
 
1          Name of Instrument
 
(1)           This Instrument is the National Health Act (Pharmaceutical Benefits – Early Supply) Amendment September 2012 - specification under subsection 84AAA(2).
 
(2)           This Instrument may also be cited as No. PB 69 of 2012.
 
2          Commencement
 
This Instrument commences on 1 September 2012.
 
 
3          Amendment of PB 30 of 2009
 
Schedule 1 amends the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009- specification under subsection 84AAA(2), PB 30 of 2009.
 
Schedule 1        Amendments
[1]                       Schedule 1, omit entry for Etidronic Acid
 
[2]                       Schedule 1, entry for Risedronic acid and calcium
omit:
 
Pack containing 4 tablets risedronate sodium 35 mg and 24 tablets calcium 500 mg (as carbonate)
Oral
1
5
 
 
[3]                       Schedule 1, entry for Verapamil
omit:
 
Tablet containing verapamil hydrochloride 160 mg
Oral
60
5
 
 
 
 
 
 
 
 
 
 
 
 
1Note
All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. 
See http://www.frli.gov.au.